一种药物排泄的注射纳米凝,用于局部向固体瘤输送抗癌药物
Brent Godau1,2, Sadaf Samimi1,2, Amir Seyfoori1,2
1Laboratory for Innovations in MicroEngineering (LiME), Department of Mechanical Engineering, University of Victoria, Victoria, BC V8P 5C2, Canada.
Pharmaceutics
|September 28, 2023
概括
这项研究开发了一种可注射的剪切稀释水凝 (STH),用于持续的多克索鲁比输送,改善癌症治疗. 该STH水凝增强抗癌药物的效率,并减少局部治疗的副作用.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 药物输送系统 药物输送系统
背景情况:
- 系统化疗面临着药物疗效和毒性方面的挑战.
- 可注射的水凝为局部,持续的药物输送提供了一个有希望的解决方案.
- 有针对性的治疗可以改善治疗结果,并最大限度地减少副作用.
研究的目的:
- 制定和评估可注射剪切稀释水凝 (STH),用于控制多克索鲁比释放.
- 在临床前癌症模型中评估基于STH的多克索鲁比辛的抗癌疗效和全身毒性.
- 研究STH在局部长期治疗乳腺癌和质母细胞瘤方面的潜力.
主要方法:
- 剪切稀释水凝 (STH) 的系统配方和表征.
- 评估水凝的物理性质,降解和多克索鲁比释放动力学.
- 在2D细胞培养,芯片上的瘤模型和乳腺癌和质母细胞瘤的小动物模型中进行测试.
主要成果:
- 开发的STH证明了可调节的,长期释放的多克索鲁比 (长达80天).
- 在临床前模型中,STH水凝显著增强了抗癌疗效.
- 在体内研究表明,乳腺癌和质母细胞瘤模型的生存率增加,系统毒性降低.
结论:
- 可注射的剪切稀释水凝在癌症治疗中有效用于局部的多克索鲁比辛输送.
- STH水凝为减少化疗副作用和治疗频率提供了一个有希望的平台.
- 这种方法具有很大的潜力,用于局部化,较少频繁地治疗瘤疾病.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


